3 Areas of Opportunity for Private Equity Investment in Life Sciences


The life sciences investment space has been largely immune to the negative impacts of the COVID-19 pandemic. Growth in the pharmaceutical, biotechnology and medical device industries has led to increased interest from private equity investors, many of which are new to the life sciences market.

In this video we address:

  • Three areas ripe for private equity investment in the life sciences arena
  • Sector-specific due diligence concerns investors should address
  • Opportunities for ROI when investing in life sciences and life sciences adjacent companies

Dig Deeper

Webinar / McDermott Event / March 9-12, 2021

HPE Miami 2021

Webinar / Cancer Treatment Centers of America / February 25, 2021

CTCA's Understanding and Addressing Health Disparities in Cancer Care (LIVE Webcast)

Virtual Event Series / McDermott Event / January 21 – February 4, 2021

9th McDermott International Japan Seminar | Virtual Event Series

Get In Touch